Collagen Remodeling Along Cancer Progression Providing a Novel Opportunity for Cancer Diagnosis and Treatment

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2022 Sep 23

PMID 36142424

Authors

Kena Song

Zhangqing Yu

Xiangyang Zu

Guoqiang Li

ZhiGang Hu

Yun Xue

Affiliations

Soon will be listed here.

Abstract

The extracellular matrix (ECM) is a significant factor in cancer progression. Collagens, as the main component of the ECM, are greatly remodeled alongside cancer development. More and more studies have confirmed that collagens changed from a barrier to providing assistance in cancer development. In this course, collagens cause remodeling alongside cancer progression, which in turn, promotes cancer development. The interaction between collagens and tumor cells is complex with biochemical and mechanical signals intervention through activating diverse signal pathways. As the mechanism gradually clears, it becomes a new target to find opportunities to diagnose and treat cancer. In this review, we investigated the process of collagen remodeling in cancer progression and discussed the interaction between collagens and cancer cells. Several typical effects associated with collagens were highlighted in the review, such as fibrillation in precancerous lesions, enhancing ECM stiffness, promoting angiogenesis, and guiding invasion. Then, the values of cancer diagnosis and prognosis were focused on. It is worth noting that several generated fragments in serum were reported to be able to be biomarkers for cancer diagnosis and prognosis, which is beneficial for clinic detection. At a glance, a variety of reported biomarkers were summarized. Many collagen-associated targets and drugs have been reported for cancer treatment in recent years. The new targets and related drugs were discussed in the review. The mass data were collected and classified by mechanism. Overall, the interaction of collagens and tumor cells is complicated, in which the mechanisms are not completely clear. A lot of collagen-associated biomarkers are excavated for cancer diagnosis. However, new therapeutic targets and related drugs are almost in clinical trials, with merely a few in clinical applications. So, more efforts are needed in collagens-associated studies and drug development for cancer research and treatment.

Citing Articles

Spatial Proteomics by Parallel Accumulation-Serial Fragmentation Supported MALDI MS/MS Imaging: A First Glance Into Multiplexed and Spatial Peptide Identification.

Li M, Meyer L, Meier N, Witte J, Maldacker M, Seredynska A Rapid Commun Mass Spectrom. 2025; 39(9):e10006.

PMID: 39910729 PMC: 11799399. DOI: 10.1002/rcm.10006.

Multi‑omics identification of a novel signature for serous ovarian carcinoma in the context of 3P medicine and based on twelve programmed cell death patterns: a multi-cohort machine learning study.

Ye L, Long C, Xu B, Yao X, Yu J, Luo Y Mol Med. 2025; 31(1):5.

PMID: 39773329 PMC: 11707953. DOI: 10.1186/s10020-024-01036-x.

Targeting Matrix Metalloproteinases and Their Inhibitors in Melanoma.

Szczygielski O, Dabrowska E, Niemyjska S, Przylipiak A, Zajkowska M Int J Mol Sci. 2025; 25(24.

PMID: 39769318 PMC: 11676509. DOI: 10.3390/ijms252413558.

The Multifaced Role of Collagen in Cancer Development and Progression.

Lo Buglio G, Lo Cicero A, Campora S, Ghersi G Int J Mol Sci. 2025; 25(24.

PMID: 39769286 PMC: 11678882. DOI: 10.3390/ijms252413523.

CREB3L1 facilitates pancreatic tumor progression and reprograms intratumoral tumor-associated macrophages to shape an immunotherapy-resistance microenvironment.

Xu H, Xue S, Sun Y, Ma J, Li S, Wang Y J Immunother Cancer. 2025; 13(1.

PMID: 39762079 PMC: 11749327. DOI: 10.1136/jitc-2024-010029.

References

Ding Y, Sun S, Zhao G . COL5A2 as a potential clinical biomarker for gastric cancer and renal metastasis. Medicine (Baltimore). 2021; 100(7):e24561. PMC: 7899835. DOI: 10.1097/MD.0000000000024561. View

Ioachim E, Michael M, Stavropoulos N, Kitsiou E, Salmas M, Malamou-Mitsi V . A clinicopathological study of the expression of extracellular matrix components in urothelial carcinoma. BJU Int. 2005; 95(4):655-9. DOI: 10.1111/j.1464-410X.2005.05357.x. View

Bayer S, Grither W, Brenot A, Hwang P, Barcus C, Ernst M . DDR2 controls breast tumor stiffness and metastasis by regulating integrin mediated mechanotransduction in CAFs. Elife. 2019; 8. PMC: 6555593. DOI: 10.7554/eLife.45508. View

Wu Y, Zhao Y, He X, He Z, Wang T, Wan L . Hydroxypropyl‑β‑cyclodextrin attenuates the epithelial‑to‑mesenchymal transition via endoplasmic reticulum stress in MDA‑MB‑231 breast cancer cells. Mol Med Rep. 2019; 21(1):249-257. PMC: 6896369. DOI: 10.3892/mmr.2019.10802. View

Lu Q, Chen W, Peng J, Xu Y, Cai Q, Feng G . Antitumor activity of 7RH, a discoidin domain receptor 1 inhibitor, alone or in combination with dasatinib exhibits antitumor effects in nasopharyngeal carcinoma cells. Oncol Lett. 2016; 12(5):3598-3608. PMC: 5104140. DOI: 10.3892/ol.2016.5088. View

Ambekar R, Lau T, Walsh M, Bhargava R, Toussaint Jr K . Quantifying collagen structure in breast biopsies using second-harmonic generation imaging. Biomed Opt Express. 2012; 3(9):2021-35. PMC: 3447546. DOI: 10.1364/BOE.3.002021. View

Subbaram S, DiPersio C . Integrin α3β1 as a breast cancer target. Expert Opin Ther Targets. 2011; 15(10):1197-210. PMC: 3212412. DOI: 10.1517/14728222.2011.609557. View

Shibata M, Ham K, Hoque M . A time for YAP1: Tumorigenesis, immunosuppression and targeted therapy. Int J Cancer. 2018; 143(9):2133-2144. PMC: 6540999. DOI: 10.1002/ijc.31561. View

Henriet E, Sala M, Abou Hammoud A, Tuariihionoa A, Di Martino J, Ros M . Multitasking discoidin domain receptors are involved in several and specific hallmarks of cancer. Cell Adh Migr. 2018; 12(4):363-377. PMC: 6411096. DOI: 10.1080/19336918.2018.1465156. View

10.

Snijder J, Peraza J, Padilla M, Capaccione K, Salvatore M . Pulmonary fibrosis: a disease of alveolar collapse and collagen deposition. Expert Rev Respir Med. 2019; 13(7):615-619. DOI: 10.1080/17476348.2019.1623028. View

11.

Levental K, Yu H, Kass L, Lakins J, Egeblad M, Erler J . Matrix crosslinking forces tumor progression by enhancing integrin signaling. Cell. 2009; 139(5):891-906. PMC: 2788004. DOI: 10.1016/j.cell.2009.10.027. View

12.

Hanley C, Noble F, Ward M, Bullock M, Drifka C, Mellone M . A subset of myofibroblastic cancer-associated fibroblasts regulate collagen fiber elongation, which is prognostic in multiple cancers. Oncotarget. 2015; 7(5):6159-74. PMC: 4868747. DOI: 10.18632/oncotarget.6740. View

13.

Hiki Y, Iyama K, Tsuruta J, Egami H, Kamio T, Suko S . Differential distribution of basement membrane type IV collagen alpha1(IV), alpha2(IV), alpha5(IV) and alpha6(IV) chains in colorectal epithelial tumors. Pathol Int. 2002; 52(3):224-33. DOI: 10.1046/j.1440-1827.2002.01341.x. View

14.

Seko Y, Sumida Y, Tanaka S, Taketani H, Kanemasa K, Ishiba H . Predictors of malignancies and overall mortality in Japanese patients with biopsy-proven non-alcoholic fatty liver disease. Hepatol Res. 2014; 45(7):728-38. DOI: 10.1111/hepr.12407. View

15.

Hanker A, Estrada M, Bianchini G, Moore P, Zhao J, Cheng F . Extracellular Matrix/Integrin Signaling Promotes Resistance to Combined Inhibition of HER2 and PI3K in HER2 Breast Cancer. Cancer Res. 2017; 77(12):3280-3292. PMC: 5482178. DOI: 10.1158/0008-5472.CAN-16-2808. View

16.

Sumida Y, Yoneda M, Seko Y, Ishiba H, Hara T, Toyoda H . Surveillance of Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease. Diagnostics (Basel). 2020; 10(8). PMC: 7459689. DOI: 10.3390/diagnostics10080579. View

17.

Rong L, Huang W, Tian S, Chi X, Zhao P, Liu F . COL1A2 is a Novel Biomarker to Improve Clinical Prediction in Human Gastric Cancer: Integrating Bioinformatics and Meta-Analysis. Pathol Oncol Res. 2017; 24(1):129-134. DOI: 10.1007/s12253-017-0223-5. View

18.

Liu C, Liao Y, Hsieh P, Yu C, Chueh P, Lin T . miR-1246 as a therapeutic target in oral submucosa fibrosis pathogenesis. J Formos Med Assoc. 2019; 118(7):1093-1098. DOI: 10.1016/j.jfma.2019.02.014. View

19.

Zhang H, Fredericks T, Xiong G, Qi Y, Rychahou P, Li J . Membrane associated collagen XIII promotes cancer metastasis and enhances anoikis resistance. Breast Cancer Res. 2018; 20(1):116. PMC: 6167877. DOI: 10.1186/s13058-018-1030-y. View

20.

Olivares V, Condor M, Del Amo C, Asin J, Borau C, Garcia-Aznar J . Image-based Characterization of 3D Collagen Networks and the Effect of Embedded Cells. Microsc Microanal. 2019; 25(4):971-981. DOI: 10.1017/S1431927619014570. View